Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

research: tivozanib, new VEGF inhibitor in clinical trials

Posted Dec 18 2010 12:00am

A drug in Phase I clinical trials is showing good results in treatment for metastatic breast cancer when combined with paclitaxel. AVEO Pharmaceutical Company’s tivozanib is a selective VEGF receptor inhibitor. Dr. Erica L. Mayer, medical oncologist at the Breast … Continue reading

Post a comment
Write a comment:

Related Searches